AC Immune
ACIU
31 hedge funds and large institutions have $136M invested in AC Immune in 2016 Q3 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$55.4M |
| 2 |
DFO
Duquesne Family Office
New York
|
+$25.9M |
| 3 |
Temasek Holdings
Singapore
|
+$23.1M |
| 4 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
+$9.5M |
| 5 |
PC
PointState Capital
New York
|
+$7.34M |
Top Sellers
ACIU Hedge Fund Activity: Q3 2016 in Review
31 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2016, worth a combined $136M.
Buyers outnumbered sellers: 31 funds opened new ACIU positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $55.4M.
- 31 institutional investors held AC Immune (ACIU) as of Q3 2016, up from 0 in Q2 2016.
- Funds reported $136M of AC Immune stock for Q3 2016.
- 31 funds opened new AC Immune positions in Q3 2016 and 0 closed out, a net change of +31 holders.
- The largest AC Immune buyer in Q3 2016 was Fidelity Investments, an estimated $55.4M added.
Based on aggregated 13F filings for Q3 2016.